Tablet comprising 7-[4-(4-benzo[b]thiophen-4-yl-piperazin-1-yl)butoxy]-1h-quinolin-2-one or a salt thereof
Abstract
This invention relates to a tablet containing, as an active ingredient, 7-[4-(4-benzo[b]thiophen-4-yl-piperazin-1-yl)butoxy]-1H-quinolin-2-one or a salt thereof, that has excellent disintegration ability, storage stability and photostability. The tablet of the present invention comprising an uncoated tablet containing 7-[4-(4-benzo[b]thiophen-4-yl-piperazin-1-yl)butoxy]-1H-quinolin-2-one or a salt thereof as an active ingredient, excipients such as lactose, corn starch, and microcrystalline cellulose; disintegrants such as low-substituted hydroxypropylcellulose, croscarmellose sodium, and sodium carboxymethyl starch; binders such as hydroxypropylcellulose; lubricants such as stearate; and further comprising a coating layer containing hypromellose; talc; titanium oxide; colorant; and the like, the coating layer being applied to the surface of the uncoated tablet.
Claims
exact text as granted — not AI-modified1 . A tablet comprising 7-[4-(4-benzo[b]thiophen-4-yl-piperazin-1-yl)butoxy]-1H-quinolin-2-one or a salt thereof as an active ingredient.
2 . The tablet according to claim 1 , further comprising:
an excipient (a), a binder (b), a disintegrant (c) and a lubricant (d), wherein the excipient (a) is at least one member selected from the group consisting of sugars, sugar alcohols, starches, and celluloses; the binder (b) is a cellulose derivative; the disintegrant (c) is at least one member selected from the group consisting of cellulose derivatives and starch derivatives; and the lubricant (d) is a stearate.
3 . The tablet according to claim 2 ,
wherein the excipient (a) is at least one member selected from the group consisting of lactose, corn starch, and microcrystalline cellulose; the binder (b) is hydroxypropyl cellulose; the disintegrant (c) is at least one member selected from the group consisting of low-substituted hydroxypropyl cellulose, croscarmellose sodium, and sodium carboxymethyl starch; and the lubricant (d) is magnesium stearate.
4 . The tablet according to claim 2 or 3 , wherein the tablet is an uncoated tablet comprising:
0.05 to 25% by weight of 7-[4-(4-benzo[b]thiophen-4-yl-piperazin-1-yl)butoxy]-1H-quinolin-2-one or a salt thereof;
10 to 98.5% by weight of the excipient (a);
0.1 to 20% by weight of the binder (b);
1 to 25% by weight of the disintegrant (c); and
0.1 to 10% by weight of the lubricant (d), with respect to the weight of the uncoated tablet.
5 . The tablet according to any one of claims 2 to 4 , wherein per 1 part by weight of 7-[4-(4-benzo[b]thiophen-4-yl-piperazin-1-yl)butoxy]-1H-quinolin-2-one or a salt thereof, the tablet comprises:
1 to 2000 parts by weight of the excipient (a);
0.01 to 100 parts by weight of the binder (b);
0.1 to 500 parts by weight of the disintegrant (c); and
0.01 to 50 parts by weight of the lubricant (d).
6 . The tablet according to any one of claims 1 to 5 , which further comprises a coating layer on the surface thereof.
7 . The tablet according to claim 6 , which further comprises the colorant (e) in the coating layer,
wherein the colorant (e) contains an iron oxide, and the tablet contains 0.1 to 50% by weight of the colorant (e) with respect to the weight of the coating layer.
8 . The tablet according to any one of claims 1 to 7 , which is obtained by forming, into a tablet, a granulated substance obtained through wet granulation.
9 . The tablet according to any one of claims 1 to 8 , wherein the tablet does not contain povidone or crospovidone.
10 . A method for producing a tablet, the method comprising the steps of:
(1) granulating a mixture containing 7-[4-(4-benzo[b]thiophen-4-yl-piperazin-1-yl)butoxy]-1H-quinolin-2-one or a salt thereof, an excipient (a), a binder (b), and a disintegrant (c), and further mixing thereto a lubricant (d); and (2) forming the obtained mixture into a tablet, wherein the excipient (a) is at least one member selected from the group consisting of sugars, sugar alcohols, starches, and celluloses; the binder (b) is a cellulose derivative; the disintegrant (c) is at least one member selected from the group consisting of cellulose derivatives and starch derivatives; and the lubricant (d) is a stearate.
11 . The method for producing the tablet according to claim 10 , further comprising the step of:
(3) mixing a coating agent, a colorant (e), and a liquid medium to obtain a mixture, and coating the surface of the tablet using the mixture.Join the waitlist — get patent alerts
Track US2019240215A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.